loadpatents
name:-0.059389114379883
name:-0.04458212852478
name:-0.016802072525024
van Duzer; John H. Patent Filings

van Duzer; John H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for van Duzer; John H..The latest application filed is for "substituted piperazines as selective hdac1,2 inhibitors".

Company Profile
15.46.54
  • van Duzer; John H. - Concord MA
  • van Duzer; John H. - Georgetown MA
  • Van Duzer; John H - Georgetown MA
  • van Duzer; John H. - Boston MA
  • Van Duzer, John H. - Asbury NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted Piperazines As Selective Hdac1,2 Inhibitors
App 20220281833 - van Duzer; John H. ;   et al.
2022-09-08
HDAC1,2 Inhibitors
App 20220033388 - VAN DUZER; John H. ;   et al.
2022-02-03
Pyrimidine And Pyrazine Hdac1,2 Inhibitors
App 20210332036 - VAN DUZER; John H. ;   et al.
2021-10-28
Piperidine Derivatives As Hdac1/2 Inhibitors
App 20210179559 - van Duzer; John H. ;   et al.
2021-06-17
Piperidine derivatives as HDAC1/2 inhibitors
Grant 10,968,180 - van Duzer , et al. April 6, 2
2021-04-06
Phenyl and pyridinyl hydroxamic acids
Grant 10,927,072 - van Duzer , et al. February 23, 2
2021-02-23
Substituted Piperazines As Selective Hdac1,2 Inhibitors
App 20200377465 - van Duzer; John H. ;   et al.
2020-12-03
Substituted piperazines as selective HDAC1,2 inhibitors
Grant 10,774,056 - van Duzer , et al. Sept
2020-09-15
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
App 20200030325 - van Duzer; John H. ;   et al.
2020-01-30
Phenyl And Pyridinyl Hydroxamic Acids
App 20200010407 - van Duzer; John H. ;   et al.
2020-01-09
Piperidine Derivatives As Hdac1/2 Inhibitors
App 20190359569 - van Duzer; John H. ;   et al.
2019-11-28
Crystalline forms of a histone deacetylase inhibitor
Grant 10,464,906 - van Duzer , et al. No
2019-11-05
Selective Hdac1,2 Inhibitors
App 20190330169 - van Duzer; John H. ;   et al.
2019-10-31
Substituted piperazines as selective HDAC1,2 inhibitors
Grant 10,385,031 - van Duzer , et al. A
2019-08-20
Phenyl and pyridinyl hydroxamic acids
Grant 10,370,324 - van Duzer , et al.
2019-08-06
Piperidine derivatives as HDAC1/2 inhibitors
Grant 10,358,421 - van Duzer , et al.
2019-07-23
Piperidine derivatives as HDAC1/2 inhibitors
Grant 10,239,837 - van Duzer , et al.
2019-03-26
Methods of making protein deacetylase inhibitors
Grant 10,144,714 - Seyedi , et al. De
2018-12-04
Selective HDAC3 inhibitors
Grant 10,125,131 - van Duzer , et al. November 13, 2
2018-11-13
Selective Hdac1,2 Inhibitors
App 20180141923 - van Duzer; John H. ;   et al.
2018-05-24
Phenyl And Pyridinyl Hydroxamic Acids
App 20180127356 - van Duzer; John H. ;   et al.
2018-05-10
Selective HDAC1 and HDAC2 inhibitors
Grant 9,957,259 - van Duzer , et al. May 1, 2
2018-05-01
Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
Grant 9,884,850 - Mazitschek , et al. February 6, 2
2018-02-06
Selective Hdac1 And Hdac2 Inhibitors
App 20180030040 - van Duzer; John H. ;   et al.
2018-02-01
Piperidine Derivatives As Hdac1/2 Inhibitors
App 20180022702 - van Duzer; John H. ;   et al.
2018-01-25
Piperidine Derivatives As Hdac1/2 Inhibitors
App 20170369441 - van Duzer; John H. ;   et al.
2017-12-28
Piperidine derivatives as HDAC1/2 inhibitors
Grant 9,790,180 - van Duzer , et al. October 17, 2
2017-10-17
Selective HDAC1 and HDAC2 inhibitors
Grant 9,765,066 - van Duzer , et al. September 19, 2
2017-09-19
Hdac1/2 Inhibitors For The Treatment Of Neurodegenerative And/or Cognitive Disorders
App 20170240535 - van Duzer; John H. ;   et al.
2017-08-24
Selective HDAC3 Inhibitors
App 20170204094 - van Duzer; John H. ;   et al.
2017-07-20
Pyrimidine Hydroxy Amide Compounds As Hdac6 Selective Inhibitors
App 20170096413 - Mazitschek; Ralph ;   et al.
2017-04-06
Pyrimidine Hydroxy Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
App 20170096403 - van Duzer; John H. ;   et al.
2017-04-06
Selective Hdac1 And Hdac2 Inhibitors
App 20170044144 - van Duzer; John H. ;   et al.
2017-02-16
Selective HDAC3 inhibitors
Grant 9,562,013 - van Duzer , et al. February 7, 2
2017-02-07
Crystalline Forms Of A Histone Deacetylase Inhibitor
App 20170001965 - van Duzer; John H. ;   et al.
2017-01-05
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
App 20160375021 - van Duzer; John H. ;   et al.
2016-12-29
Methods Of Making Protein Deacetylase Inhibitors
App 20160355486 - Seyedi; Farzaneh ;   et al.
2016-12-08
Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
Grant 9,464,073 - Mazitschek , et al. October 11, 2
2016-10-11
Pyrimidine Hydroxy Amide Compounds As Histone Deacetylase Inhibitors
App 20160279128 - van Duzer; John H. ;   et al.
2016-09-29
Selective HDAC1 and HDAC2 inhibitors
Grant 9,421,212 - van Duzer , et al. August 23, 2
2016-08-23
Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
Grant 9,409,890 - van Duzer , et al. August 9, 2
2016-08-09
Piperidine Derivatives As Hdac1/2 Inhibitors
App 20160168093 - van Duzer; John H. ;   et al.
2016-06-16
Selective Hdac1 And Hdac2 Inhibitors
App 20160067259 - van Duzer; John H. ;   et al.
2016-03-10
Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
Grant 9,278,963 - van Duzer , et al. March 8, 2
2016-03-08
Selective Hdac3 Inhibitors
App 20150299130 - van Duzer; John H. ;   et al.
2015-10-22
Selective HDAC1 and HDAC2 inhibitors
Grant 9,145,412 - van Duzer , et al. September 29, 2
2015-09-29
Selective HDAC3 inhibitors
Grant 9,139,583 - van Duzer , et al. September 22, 2
2015-09-22
Pyrimidine Hydroxy Amide Compounds As Hdac6 Selective Inhibitors
App 20150239869 - Mazitschek; Ralph ;   et al.
2015-08-27
Selective HDAC3 inhibitors
Grant 9,096,549 - van Duzer , et al. August 4, 2
2015-08-04
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
App 20150045380 - van Duzer; John H. ;   et al.
2015-02-12
Selective Hdac3 Inhibitors
App 20140249148 - van Duzer; John H. ;   et al.
2014-09-04
Selective Hdac3 Inhibitors
App 20140243345 - van Duzer; John H. ;   et al.
2014-08-28
Pyrimidine Hydroxy Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
App 20140142104 - van Duzer; John H. ;   et al.
2014-05-22
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
App 20140142117 - van Duzer; John H. ;   et al.
2014-05-22
Selective Hdac1 And Hdac2 Inhibitors
App 20140128391 - van Duzer; John H. ;   et al.
2014-05-08
Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
Grant 8,614,223 - van Duzer , et al. December 24, 2
2013-12-24
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
Grant 8,609,678 - Van Duzer , et al. December 17, 2
2013-12-17
Polyal drug conjugates comprising variable rate-releasing linkers
Grant 8,524,214 - Yurkovetskiy , et al. September 3, 2
2013-09-03
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
Grant 8,394,810 - van Duzer , et al. March 12, 2
2013-03-12
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
App 20120190693 - van Duzer; John H. ;   et al.
2012-07-26
Pyrimidine Hydroxy Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
App 20120121502 - van Duzer; John H. ;   et al.
2012-05-17
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
App 20120083504 - van Duzer; John H. ;   et al.
2012-04-05
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
Grant 8,148,526 - van Duzer , et al. April 3, 2
2012-04-03
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
App 20110300134 - van Duzer; John H. ;   et al.
2011-12-08
Polyal Drug Conjugates Comprising Variable Rate-Releasing Linkers
App 20100305149 - Yurkovetskiy; Aleksandr ;   et al.
2010-12-02
Rifamycin analogs and uses thereof
App 20100273765 - van Duzer; John H. ;   et al.
2010-10-28
Rifamycin analogs and uses thereof
Grant 7,547,692 - van Duzer , et al. June 16, 2
2009-06-16
Rifamycin analogs and uses thereof
Grant 7,494,991 - van Duzer , et al. February 24, 2
2009-02-24
Rifamycin analogs and uses thereof
Grant 7,488,726 - Van Duzer , et al. February 10, 2
2009-02-10
Isoquinoline Derivatives And Methods Of Use Thereof
App 20080262016 - Jagtap; Prakash ;   et al.
2008-10-23
Rifamycin analogs and uses thereof
Grant 7,342,011 - van Duzer , et al. March 11, 2
2008-03-11
Rifamycin analogs and uses thereof
App 20070238747 - van Duzer; John H. ;   et al.
2007-10-11
Rifamycin analogs and uses thereof
Grant 7,271,165 - van Duzer , et al. September 18, 2
2007-09-18
Rifamycin analogs and uses thereof
App 20070155715 - van Duzer; John H. ;   et al.
2007-07-05
Rifamycin analogs and uses thereof
Grant 7,220,738 - van Duzer , et al. May 22, 2
2007-05-22
Rifamycin analogs and uses thereof
App 20070105849 - Van Duzer; John H. ;   et al.
2007-05-10
Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
Grant 7,115,662 - Fujimoto , et al. October 3, 2
2006-10-03
Isoquinoline derivatives and methods of use thereof
Grant 6,956,035 - Jagtap , et al. October 18, 2
2005-10-18
Isoquinoline derivatives and methods of use thereof
App 20050228007 - Jagtap, Prakash ;   et al.
2005-10-13
Rifamycin analogs and uses thereof
App 20050197333 - van Duzer, John H. ;   et al.
2005-09-08
Rifamycin analogs and uses thereof
App 20050137189 - van Duzer, John H. ;   et al.
2005-06-23
Isoquinoline derivatives and methods of use thereof
App 20050049270 - Jagtap, Prakash ;   et al.
2005-03-03
Rifamycin analogs and uses thereof
App 20050043298 - van Duzer, John H. ;   et al.
2005-02-24
Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
Grant 6,828,319 - Jagtap , et al. December 7, 2
2004-12-07
Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
App 20040122254 - Fujimoto, Roger A. ;   et al.
2004-06-24
Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
Grant 6,727,281 - Fujimoto , et al. April 27, 2
2004-04-27
Isoquinoline derivatives and methods of use thereof
App 20040039009 - Jagtap, Prakash ;   et al.
2004-02-26
Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
App 20030171392 - Jagtap, Prakash ;   et al.
2003-09-11
Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof
App 20030096833 - Jagtap, Prakash G. ;   et al.
2003-05-22
Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
App 20020183391 - Fujimoto, Roger A. ;   et al.
2002-12-05
Certain 5-alkyl-2arylaminophenylacetic acids and derivatives
App 20020013369 - Fujimoto, Roger A. ;   et al.
2002-01-31
Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
Grant 6,291,523 - Fujimoto , et al. September 18, 2
2001-09-18
2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin -4-ones
Grant 6,174,888 - McQuire , et al. January 16, 2
2001-01-16
Indolyl substituted hydroxylamine derivatives
Grant 5,350,761 - Van Duzer , et al. September 27, 1
1994-09-27
Isoquinolyl substituted hydroxylamine derivatives
Grant 5,334,600 - Van Duzer , et al. August 2, 1
1994-08-02
Isoquinolyl substituted hydroxylamine derivatives
Grant 5,260,316 - Van Duzer , et al. November 9, 1
1993-11-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed